Literature DB >> 17638849

The Shc-binding site of the betac subunit of the GM-CSF/IL-3/IL-5 receptors is a negative regulator of hematopoiesis.

Hayley S Ramshaw1, Mark A Guthridge, Frank C Stomski, Emma F Barry, Lisa Ooms, Christina A Mitchell, C Glenn Begley, Angel F Lopez.   

Abstract

Tyrosine and serine phosphorylation of the common beta chain (beta(c)) of the granulocyte-macrophage colony-stimulating factor (GM-CSF), interleukin-3 (IL-3), and IL-5 receptors is widely viewed as a general mechanism that provides positive inputs by coupling the receptor to signaling pathways that stimulate several cellular functions. We show here that despite the known action of Tyr577 in beta(c) to recruit Shc-PI-3 kinase (PI3K) pathway members, Tyr577 plays, surprisingly, a negative regulatory role in cell function, and that this is mediated, at least in part, through the uncoupling of SH2-containing inositol 5'-phosphatase (SHIP) from beta(c). Fetal liver cells from beta(c)/beta(IL-3)(-/-) mice expressing human GM-CSF receptor alpha chain and beta(c) Tyr577Phe mutant showed enhanced colony formation and expansion of progenitor cells in response to GM-CSF. Dissection of these activities revealed that basal survival was increased, as well as cytokine-stimulated proliferation. As expected, the recruitment and activation of Shc was abolished, but interestingly, Gab-2 and Akt phosphorylation increased. Significantly, the activation of PI3K was enhanced and prolonged, accompanied by loss of SHIP activity. These results reveal a previously unrecognized negative signaling role for Tyr577 in beta(c) and demonstrate that uncoupling Shc from cytokine receptors enhances PI3K signaling as well as survival and proliferation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17638849      PMCID: PMC2077308          DOI: 10.1182/blood-2007-01-070391

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  60 in total

Review 1.  IL-3 signaling and the role of Src kinases, JAKs and STATs: a covert liaison unveiled.

Authors:  E P Reddy; A Korapati; P Chaturvedi; S Rane
Journal:  Oncogene       Date:  2000-05-15       Impact factor: 9.867

2.  The ShcA phosphotyrosine docking protein sensitizes cardiovascular signaling in the mouse embryo.

Authors:  K M Lai; T Pawson
Journal:  Genes Dev       Date:  2000-05-01       Impact factor: 11.361

Review 3.  The suppressors of cytokine signaling (SOCS) proteins: important feedback inhibitors of cytokine action.

Authors:  N A Nicola; C J Greenhalgh
Journal:  Exp Hematol       Date:  2000-10       Impact factor: 3.084

4.  Shc associates with the IL-3 receptor beta subunit, SHIP and Gab2 following IL-3 stimulation. Contribution of Shc PTB and SH2 domains.

Authors:  H Bone; M J Welham
Journal:  Cell Signal       Date:  2000-03       Impact factor: 4.315

5.  Cloning and characterization of a 72-kDa inositol-polyphosphate 5-phosphatase localized to the Golgi network.

Authors:  A M Kong; C J Speed; C J O'Malley; M J Layton; T Meehan; K L Loveland; S Cheema; L M Ooms; C A Mitchell
Journal:  J Biol Chem       Date:  2000-08-04       Impact factor: 5.157

6.  Two distinct signaling pathways downstream of Janus kinase 2 play redundant roles for antiapoptotic activity of granulocyte-macrophage colony-stimulating factor.

Authors:  R Liu; T Itoh; K I Arai; S Watanabe
Journal:  Mol Biol Cell       Date:  1999-11       Impact factor: 4.138

7.  New role for Shc in activation of the phosphatidylinositol 3-kinase/Akt pathway.

Authors:  H Gu; H Maeda; J J Moon; J D Lord; M Yoakim; B H Nelson; B G Neel
Journal:  Mol Cell Biol       Date:  2000-10       Impact factor: 4.272

8.  The shc adaptor protein forms interdependent phosphotyrosine-mediated protein complexes in mast cells stimulated with interleukin 3.

Authors:  L Velazquez; G D Gish; P van Der Geer; L Taylor; J Shulman; T Pawson
Journal:  Blood       Date:  2000-07-01       Impact factor: 22.113

9.  Site-specific serine phosphorylation of the IL-3 receptor is required for hemopoietic cell survival.

Authors:  M A Guthridge; F C Stomski; E F Barry; W Winnall; J M Woodcock; B J McClure; M Dottore; M C Berndt; A F Lopez
Journal:  Mol Cell       Date:  2000-07       Impact factor: 17.970

10.  Suppressor of cytokine signaling 3 controls lysosomal routing of G-CSF receptor.

Authors:  Mahban I Irandoust; Lambertus H J Aarts; Onno Roovers; Judith Gits; Stefan J Erkeland; Ivo P Touw
Journal:  EMBO J       Date:  2007-03-15       Impact factor: 11.598

View more
  7 in total

1.  Loss of GM-CSF signalling in non-haematopoietic cells increases NSAID ileal injury.

Authors:  Xiaonan Han; Shila Gilbert; Katherine Groschwitz; Simon Hogan; Ingrid Jurickova; Bruce Trapnell; Charles Samson; Jonathan Gully
Journal:  Gut       Date:  2010-06-28       Impact factor: 23.059

Review 2.  Cytokine receptor splice variants in hematologic diseases.

Authors:  Borwyn Wang; Hrishikesh Mehta
Journal:  Cytokine       Date:  2019-12-06       Impact factor: 3.861

3.  The proximal signaling network of the BCR-ABL1 oncogene shows a modular organization.

Authors:  B Titz; T Low; E Komisopoulou; S S Chen; L Rubbi; T G Graeber
Journal:  Oncogene       Date:  2010-08-09       Impact factor: 9.867

4.  The GM-CSF receptor utilizes β-catenin and Tcf4 to specify macrophage lineage differentiation.

Authors:  Anna L Brown; Diana G Salerno; Teresa Sadras; Grant A Engler; Chung H Kok; Christopher R Wilkinson; Saumya E Samaraweera; Timothy J Sadlon; Michelle Perugini; Ian D Lewis; Thomas J Gonda; Richard J D'Andrea
Journal:  Differentiation       Date:  2011-10-08       Impact factor: 3.880

Review 5.  The granulocyte-macrophage colony-stimulating factor receptor: linking its structure to cell signaling and its role in disease.

Authors:  Timothy R Hercus; Daniel Thomas; Mark A Guthridge; Paul G Ekert; Jack King-Scott; Michael W Parker; Angel F Lopez
Journal:  Blood       Date:  2009-05-12       Impact factor: 22.113

6.  Aberrant antibody affinity selection in SHIP-deficient B cells.

Authors:  Wai-Hang Leung; Tatiana Tarasenko; Zuzana Biesova; Hemanta Kole; Elizabeth R Walsh; Silvia Bolland
Journal:  Eur J Immunol       Date:  2012-12-12       Impact factor: 5.532

7.  Suppressor of Cytokine Signaling (SOCS) 5 utilises distinct domains for regulation of JAK1 and interaction with the adaptor protein Shc-1.

Authors:  Edmond M Linossi; Indu R Chandrashekaran; Tatiana B Kolesnik; James M Murphy; Andrew I Webb; Tracy A Willson; Lukasz Kedzierski; Alex N Bullock; Jeffrey J Babon; Raymond S Norton; Nicos A Nicola; Sandra E Nicholson
Journal:  PLoS One       Date:  2013-08-21       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.